Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00FOZ
|
|||
Former ID |
DNC010430
|
|||
Drug Name |
Propan-2-one O-3-butoxyphenylcarbamoyl oxime
|
|||
Synonyms |
CHEMBL597130; propan-2-one O-3-butoxyphenylcarbamoyl oxime
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H20N2O3
|
|||
Canonical SMILES |
CCCCOC1=CC=CC(=C1)NC(=O)ON=C(C)C
|
|||
InChI |
1S/C14H20N2O3/c1-4-5-9-18-13-8-6-7-12(10-13)15-14(17)19-16-11(2)3/h6-8,10H,4-5,9H2,1-3H3,(H,15,17)
|
|||
InChIKey |
GNTLUXBWYDMBFL-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
BioCyc | Anandamide degradation | |||
KEGG Pathway | Retrograde endocannabinoid signaling | |||
Panther Pathway | Anandamide degradation |
References | Top | |||
---|---|---|---|---|
REF 1 | Oxime carbamate--discovery of a series of novel FAAH inhibitors. Bioorg Med Chem Lett. 2010 Feb 1;20(3):1272-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.